Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

C3 anticorps

L’anticorps Rat Monoclonal anti-C3 a été validé pour IP. Il convient pour détecter C3 dans des échantillons de Humain.
N° du produit ABIN1106774

Aperçu rapide pour C3 anticorps (ABIN1106774)

Antigène

Voir toutes C3 Anticorps
C3 (Complement Component 3 (C3))

Reactivité

  • 107
  • 54
  • 36
  • 6
  • 5
  • 4
  • 3
  • 3
  • 2
  • 1
Humain

Hôte

  • 80
  • 44
  • 37
  • 7
  • 7
  • 5
  • 1
Rat

Clonalité

  • 133
  • 47
Monoclonal

Conjugué

  • 83
  • 24
  • 23
  • 12
  • 4
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp C3 est non-conjugé

Application

  • 113
  • 52
  • 43
  • 38
  • 37
  • 33
  • 31
  • 30
  • 28
  • 23
  • 22
  • 13
  • 13
  • 8
  • 5
  • 5
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Immunoprecipitation (IP)

Clone

4
  • Réactivité croisée (Details)

    Species reactivity (tested):Human

    Purification

    Protein G

    Isotype

    IgG2a
  • Indications d'application

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Concentration

    0.1 mg/mL

    Buffer

    PBS, 0.02 % sodium azide, 0.1 % bovine serum albumin

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    4 °C

    Stockage commentaire

    Store at 2 - 8 °C.
  • Antigène

    C3 (Complement Component 3 (C3))

    Autre désignation

    Complement C3

    Sujet

    The complement system is an important factor in innate immunity. The third complement component, C3, is central to the classical, alternative and lectin pathways of complement activation. Activation products of the complement cascade contain neo-epitopes that are not present in the individual native components. The synthesis of C3 is tissue-specific and is modulated in response to a variety of stimulatory agents. C3 is the most abundant protein of the complement system with serum protein levels of about 1.3 mg/mL. An inherited deficiency of C3 predisposes the person to frequent bacterial infections. C3 fragments are deposited in tissues at sites of antibody-mediated immunopathology. In ulcerative colitis and idiopathic chronic inflammatory bowel disease, the deposition of C3 in the diseased mucosa has been reported. Proteolysis by C3-convertases results in the cleavage of C3 into C3a and C3b. C3b becomes attached to immune complexes and is further cleaved into iC3b and C3f. iC3b is further processed into C3c and C3dg.Synonyms: C3 and PZP-like alpha-2-macroglobulin domain-containing protein 1, CPAMD1, Complement component 3

    ID gène

    9606

    UniProt

    P01024

    Pathways

    Système du Complément, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Regulation of G-Protein Coupled Receptor Protein Signaling
Vous êtes ici:
Chat with us!